Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
284.23
-2.93 (-1.02%)
Aug 14, 2025, 11:46 AM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Life Science | 1.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Growth | -1.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics | 1.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Growth | 0.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
| Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -83.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -83.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Segment Profit | 582.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Segment Profit Growth | 2.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Segment Profit | 796.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Segment Profit Growth | -6.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Segment Profit | -100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -83.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| United States | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -0.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA | 834.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | 4.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC | 521.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Growth | -5.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regional | 169.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regional Growth | -6.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|